Detalles de la búsqueda
1.
Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: Lessons from therapeutic modalities targeting Fcγ receptors.
J Allergy Clin Immunol
; 146(3): 492-500, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32721416
2.
Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases.
J Autoimmun
; 111: 102435, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360069
3.
Epratuzumab modulates B-cell signaling without affecting B-cell numbers or B-cell functions in a mouse model with humanized CD22.
Eur J Immunol
; 46(9): 2260-72, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27352780
4.
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro.
MAbs
; 16(1): 2300155, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241085
5.
Membrane Proteome-Wide Screening of Autoantibodies in CIDP Using Human Cell Microarray Technology.
Neurol Neuroimmunol Neuroinflamm
; 11(3): e200216, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38484217
6.
Pharmacokinetic-pharmacodynamic modelling of the anti-FcRn monoclonal antibody rozanolixizumab: Translation from preclinical stages to the clinic.
CPT Pharmacometrics Syst Pharmacol
; 11(1): 116-128, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34735735
7.
Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune Encephalomyelitis.
Neurol Neuroimmunol Neuroinflamm
; 9(2)2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35027475
8.
Inhibition of Maternal-to-Fetal Transfer of IgG Antibodies by FcRn Blockade in a Mouse Model of Arthrogryposis Multiplex Congenita.
Neurol Neuroimmunol Neuroinflamm
; 8(4)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34045306
9.
Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation.
J Exp Med
; 196(11): 1515-21, 2002 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-12461086
10.
Treatment with anti-neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in mice.
Br J Pharmacol
; 177(10): 2381-2392, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31975370
11.
Generation of two high affinity anti-mouse FcRn antibodies: Inhibition of IgG recycling in wild type mice and effect in a mouse model of immune thrombocytopenia.
Int Immunopharmacol
; 66: 362-365, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30529500
12.
Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials.
Arthritis Rheumatol
; 70(5): 763-773, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29381843
13.
Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling.
Arthritis Res Ther
; 19(1): 91, 2017 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28506291
14.
Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptor.
J Cell Commun Signal
; 10(2): 143-51, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27125377
15.
The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus.
Autoimmun Rev
; 14(12): 1079-86, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26212727
16.
Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients.
Arthritis Res Ther
; 17: 185, 2015 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26183319
17.
CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study.
Arthritis Res Ther
; 17: 234, 2015 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26335795
18.
CD22 and autoimmune disease.
Int Rev Immunol
; 31(5): 363-78, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23083346
19.
Discovery and evaluation of N-(triazin-1,3,5-yl) phenylalanine derivatives as VLA-4 integrin antagonists.
Bioorg Med Chem Lett
; 12(12): 1591-4, 2002 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-12039569
20.
N-(pyrimidin-4-yl) and N-(pyridin-2-yl) phenylalanine derivatives as VLA-4 integrin antagonists.
Bioorg Med Chem Lett
; 12(12): 1595-8, 2002 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-12039570